<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font17">compound </span>
   <span class="font14">against </span>
   <span class="font14">was </span>
   <span class="font13">growth </span>
   <span class="font13">cell </span>
   <span class="font13">compounds </span>
   <span class="font12">inhibition </span>
   <span class="font12">activity </span>
   <span class="font12">cancer </span>
   <span class="font12">for </span>
   <span class="font12">with </span>
   <span class="font12">moiety </span>
   <span class="font12">The </span>
   <span class="font12">that </span>
   <span class="font11">cells </span>
   <span class="font11">were </span>
   <span class="font11">hit </span>
   <span class="font11">lines </span>
   <span class="font11">which </span>
   <span class="font11">Figure </span>
   <span class="font11">kinase </span>
   <span class="font11">{background </span>
   <span class="font11">(Figure </span>
   <span class="font11">from </span>
   <span class="font11">might </span>
   <span class="font11">showed </span>
   <span class="font11">this </span>
   <span class="font11">are </span>
   <span class="font11">CSFR </span>
   <span class="font11">antiproliferative </span>
   <span class="font11">inhibited </span>
   <span class="font11">other </span>
   <span class="font11">cancers </span>
   <span class="font11">human </span>
   <span class="font11">DAPK </span>
   <span class="font11">binding </span>
   <span class="font11">margin </span>
   <span class="font10">Jâ€‰=â€‰.â€‰Hz), </span>
   <span class="font10">anticancer </span>
   <span class="font10">tested </span>
   <span class="font10">triggered </span>
   <span class="font10">{border-style </span>
   <span class="font10">potential </span>
   <span class="font10">H), </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">.%, </span>
   <span class="font10">results </span>
   <span class="font10">activities </span>
   <span class="font10">(d, </span>
   <span class="font10">.â€‰Â±â€‰. </span>
   <span class="font10">M-NFS- </span>
   <span class="font10">not </span>
   <span class="font10">relative </span>
   <span class="font10">Compound </span>
   <span class="font10">molecular </span>
   <span class="font10">resulted </span>
   <span class="font10">these </span>
   <span class="font10">Profiling </span>
   <span class="font10">active </span>
   <span class="font10">assay </span>
   <span class="font10">inhibitors </span>
   <span class="font10">line </span>
   <span class="font10">more </span>
   <span class="font10">using </span>
   <span class="font10">aâ€"h </span>
   <span class="font10">its </span>
   <span class="font10">reported </span>
   <span class="font10">starting </span>
   <span class="font10">while </span>
   <span class="font10">(s, </span>
   <span class="font10">Chem;:â€". </span>
   <span class="font10">Med </span>
   <span class="font10">doses </span>
   <span class="font10">high </span>
   <span class="font10">lead </span>
   <span class="font10">ring </span>
   <span class="font10">significantly </span>
   <span class="font10">various </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">â€‰ÂµM </span>
   <span class="font10">NMR </span>
   <span class="font10">Values </span>
   <span class="font10">assays. </span>
   <span class="font10">averages </span>
   <span class="font10">cells. </span>
   <span class="font10">development </span>
   <span class="font10">duplicate </span>
   <span class="font10">less </span>
   <span class="font10">permeability </span>
   <span class="font10">pyrimidine </span>
   <span class="font10">substituent </span>
   <span class="font10">than </span>
   <span class="font10">.... </span>
   <span class="font10">.â€". </span>
   <span class="font10">EGFR </span>
   <span class="font10">HassanAHE, </span>
   <span class="font10">Measured </span>
   <span class="font10">Research </span>
   <span class="font10">around </span>
   <span class="font10">between </span>
   <span class="font10">breast </span>
   <span class="font10">did </span>
   <span class="font10">different </span>
   <span class="font10">excellent </span>
   <span class="font10">inhibitory </span>
   <span class="font10">interactions </span>
   <span class="font10">morpholino </span>
   <span class="font10">protein </span>
   <span class="font10">renal </span>
   <span class="font10">several </span>
   <span class="font10">showing </span>
   <span class="font10">value </span>
   <span class="font10">(m, </span>
   <span class="font10">(t, </span>
   <span class="font10">(â€‰MHz, </span>
   <span class="font10">-methoxy </span>
   <span class="font10">OVCAR- </span>
   <span class="font10">Table </span>
   <span class="font10">These </span>
   <span class="font10">addition, </span>
   <span class="font10">all </span>
   <span class="font10">brain </span>
   <span class="font10">colon </span>
   <span class="font10">could </span>
   <span class="font10">diverse </span>
   <span class="font10">further </span>
   <span class="font10">good </span>
   <span class="font10">hematological </span>
   <span class="font10">into </span>
   <span class="font10">kinases </span>
   <span class="font10">low </span>
   <span class="font10">mode </span>
   <span class="font10">novel </span>
   <span class="font10">px; </span>
   <span class="font10">series </span>
   <span class="font10">significant </span>
   <span class="font10">structural </span>
   <span class="font10">study </span>
   <span class="font10">values </span>
   <span class="font10">{font-family </span>
   <span class="font10">,-dimethoxybenzamide </span>
   <span class="font10">Eur </span>
   <span class="font10">GIT </span>
   <span class="font10">However, </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Korea </span>
   <span class="font10">OVCAR-, </span>
   <span class="font10">SF- </span>
   <span class="font10">This </span>
   <span class="font10">assessment </span>
   <span class="font10">benzamide </span>
   <span class="font10">calculated </span>
   <span class="font10">cancers. </span>
   <span class="font10">data </span>
   <span class="font10">diseases </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">higher </span>
   <span class="font10">inhibit </span>
   <span class="font10">line. </span>
   <span class="font10">lung </span>
   <span class="font10">measured </span>
   <span class="font10">most </span>
   <span class="font10">obtain </span>
   <span class="font10">performed </span>
   <span class="font10">pocket </span>
   <span class="font10">prostate </span>
   <span class="font10">targets </span>
   <span class="font10">three </span>
   <span class="font10">tumour </span>
   <span class="font10">vitro </span>
   <span class="font10">.%. </span>
   <span class="font10">... </span>
   <span class="font10">CDCl): </span>
   <span class="font10">Cancer </span>
   <span class="font10">Inhibition </span>
   <span class="font10">Institute </span>
   <span class="font10">MDA-MB- </span>
   <span class="font10">Morpholino </span>
   <span class="font10">OMe </span>
   <span class="font10">Science </span>
   <span class="font10">activity. </span>
   <span class="font10">addition </span>
   <span class="font10">both </span>
   <span class="font10">cells, </span>
   <span class="font10">cellular </span>
   <span class="font10">conducted </span>
   <span class="font10">double; </span>
   <span class="font10">elicited </span>
   <span class="font10">features </span>
   <span class="font10">hydrogen </span>
   <span class="font10">illustrated </span>
   <span class="font10">lines. </span>
   <span class="font10">lower </span>
   <span class="font10">macrophages </span>
   <span class="font10">melanoma </span>
   <span class="font10">moiety, </span>
   <span class="font10">new </span>
   <span class="font10">nine </span>
   <span class="font10">only </span>
   <span class="font10">panel </span>
   <span class="font10">piperidino </span>
   <span class="font10">possessing </span>
   <span class="font10">respectively. </span>
   <span class="font10">through </span>
   <span class="font10">used </span>
   <span class="font10">within </span>
   <span class="font10">(.â€‰Â±â€‰.) </span>
   <span class="font10">(â€‰ml) </span>
   <span class="font10">,-Dimethoxy </span>
   <span class="font10">-methoxyphenoxy </span>
   <span class="font10">-position </span>
   <span class="font10">-trifluoromethyl </span>
   <span class="font10">.â€".% </span>
   <span class="font10">Arch </span>
   <span class="font10">Bioorg </span>
   <span class="font10">DAPK, </span>
   <span class="font10">HCT- </span>
   <span class="font10">HRMS </span>
   <span class="font10">NSCLC </span>
   <span class="font10">PAMPA </span>
   <span class="font10">afforded </span>
   <span class="font10">among </span>
   <span class="font10">atom </span>
   <span class="font10">biological </span>
   <span class="font10">bold </span>
   <span class="font10">bonding </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">but </span>
   <span class="font10">cancers, </span>
   <span class="font10">case </span>
   <span class="font10">chromatography </span>
   <span class="font10">design </span>
   <span class="font10">discovery </span>
   <span class="font10">docking </span>
   <span class="font10">evaluation </span>
   <span class="font10">following </span>
   <span class="font10">inhibitor </span>
   <span class="font10">lines, </span>
   <span class="font10">mixture </span>
   <span class="font10">observed </span>
   <span class="font10">ovarian </span>
   <span class="font10">permeable </span>
   <span class="font10">phenoxy </span>
   <span class="font10">poor </span>
   <span class="font10">potent </span>
   <span class="font10">promising </span>
   <span class="font10">replacement </span>
   <span class="font10">shown </span>
   <span class="font10">significance </span>
   <span class="font10">site </span>
   <span class="font10">six </span>
   <span class="font10">solid; </span>
   <span class="font10">such </span>
   <span class="font10">suggest </span>
   <span class="font10">survival </span>
   <span class="font10">their </span>
   <span class="font10">therapies. </span>
   <span class="font10">tumor-associated </span>
   <span class="font10">two </span>
   <span class="font10">weak </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(ES): </span>
   <span class="font10">(PDB </span>
   <span class="font10">-fluoroanilino </span>
   <span class="font10">-trifluoromethylphenoxy </span>
   <span class="font10">...In </span>
   <span class="font10">Additionally, </span>
   <span class="font10">CHFNO: </span>
   <span class="font10">DCM </span>
   <span class="font10">DU- </span>
   <span class="font10">ElkamhawyA, </span>
   <span class="font10">Found </span>
   <span class="font10">General </span>
   <span class="font10">Kinase </span>
   <span class="font10">MP: </span>
   <span class="font10">Mol </span>
   <span class="font10">NCI/ADR-RES, </span>
   <span class="font10">Nat </span>
   <span class="font10">Oncol;:â€". </span>
   <span class="font10">Pharm;:â€". </span>
   <span class="font10">Thus, </span>
   <span class="font10">ZIP </span>
   <span class="font10">[Mâ€‰â€‰H]. </span>
   <span class="font10">across </span>
   <span class="font10">afford </span>
   <span class="font10">agent. </span>
   <span class="font10">agents. </span>
   <span class="font10">al.Prognostic </span>
   <span class="font10">also </span>
   <span class="font10">best </span>
   <span class="font10">class </span>
   <span class="font10">code: </span>
   <span class="font10">comparing </span>
   <span class="font10">courier; </span>
   <span class="font10">derivatives </span>
   <span class="font10">despite </span>
   <span class="font10">dual </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">employing </span>
   <span class="font10">experimental </span>
   <span class="font10">factor </span>
   <span class="font10">favourable </span>
   <span class="font10">found </span>
   <span class="font10">four </span>
   <span class="font10">groups </span>
   <span class="font10">gâ€"h </span>
   <span class="font10">heterocyclic </span>
   <span class="font10">highly </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">improvement </span>
   <span class="font10">inhibition, </span>
   <span class="font10">inhibition. </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">initial </span>
   <span class="font10">instead </span>
   <span class="font10">interaction </span>
   <span class="font10">kinases. </span>
   <span class="font10">m/z </span>
   <span class="font10">medicinal </span>
   <span class="font10">membrane </span>
   <span class="font10">modification </span>
   <span class="font10">molecules </span>
   <span class="font10">obtained </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">phenyl </span>
   <span class="font10">picolinamide </span>
   <span class="font10">positive </span>
   <span class="font10">possessed </span>
   <span class="font10">possesses </span>
   <span class="font10">predicted </span>
   <span class="font10">preparation </span>
   <span class="font10">procedure </span>
   <span class="font10">profile </span>
   <span class="font10">progression </span>
   <span class="font10">protocol. </span>
   <span class="font10">pt;} </span>
   <span class="font10">pyridine </span>
   <span class="font10">receptor </span>
   <span class="font10">relatively </span>
   <span class="font10">same </span>
   <span class="font10">similar </span>
   <span class="font10">solid </span>
   <span class="font10">solid, </span>
   <span class="font10">solution </span>
   <span class="font10">solvent </span>
   <span class="font10">some </span>
   <span class="font10">structure </span>
   <span class="font10">structures </span>
   <span class="font10">target </span>
   <span class="font10">though </span>
   <span class="font10">types </span>
   <span class="font10">via </span>
   <span class="font10">yet </span>
   <span class="font10">yield </span>
   <span class="font10">â€‰Î¼M </span>
  </p>
 </body>
</html>
